Search

everythinglearnresearchcommunity

for

Search:↓

PCOS may be influenced by factors in the blood, not just the ovaries.

Hair loss is common in women with PCOS and is linked to symptoms like acne and excess hair but not to worse metabolic health.

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Finasteride and metformin both help treat PCOS, but using them together works best.

A balanced diet and healthy lifestyle help manage PCOS symptoms.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

No true link between AGA and insulin resistance, but coexistence may worsen AGA.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.